Talphera (TLPH)

• Market cap: $59.4M
• 1 day: -5.38%
• 5 days: 5.13%
• 1 month: 35.16%
• 3 months: 176.65%
• 6 months: 154.71%
• Year to date: 108.44%
• 1 year: 28.13%
• 5 years: -96.58%
• 10 years: -98.16%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Employees: 13